SCHEMBL30987199

SCHEMBL30987199

CC1(O)CCN(C(=O)OC(C)(C)C)C[C@@H](C(=O)O)OC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HPGD P15428 1/20 0.37
RECQL P46063 1/20 0.36
EPHX1 P07099 1/20 0.36
KDM4E B2RXH2 1/20 0.36
THRB P10828 1/20 0.36
RORC P51449 2/20 0.35
NR1H2 P55055 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
EPHX2 P34913 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
USP30 Q70CQ3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30987027 0.87 RORC (0.41) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL30987170 0.87 RORC (0.41) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL30987087 0.87 RORC (0.41) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL30987197 0.81 NR1H2 (0.43) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL30987166 0.80 RORC (0.40) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL59641 0.79 USP2 (0.54) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL194709 0.79 USP2 (0.54) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL194710 0.79 USP2 (0.54) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL25869375 0.79 RORC (0.39) MAPTMEN1ALDH1A1KMT2AUSP2
SCHEMBL29295638 0.77 HSD17B10 (0.38) ALDH1A1USP2SMN1; SMN2RECQLNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646265-A1 NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF Insmed Incorporated (US) 2025-11-12 EP disclosed
WO-2024148308-A1 NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF INSMED INCORPORATED (US) 2024-07-11 WO disclosed